Showing results (421-430 of 730) with videos related to
Sort By:
Pageof 73
Circulation|June 5, 2014
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)Jonathan L Halperin, Graeme J Hankey, Daniel M Wojdyla, et al.Journal of the American Heart Association|September 27, 2021
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF TrialAnthony P Carnicelli, Anne S Hellkamp, Kenneth W Mahaffey, et al.Journal of Clinical Lipidology|October 9, 2018
Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure studyChau L B Ho, Enayet K Chowdhury, Monique Breslin, et al.Journal of Hypertension|July 3, 2015
Home blood pressure monitoring: Australian Expert Consensus StatementJames E Sharman, Faline S Howes, Geoffrey A Head, et al.The Medical Journal of Australia|February 23, 2021
Absolute risk assessment for guiding cardiovascular risk management in a chest pain clinicJ Andrew Black, Julie A Campbell, Serena Parker, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 10, 2025
Socioeconomic inequalities and trends in self-reported hypertension and antihypertensive medication use in Australia between 2009 and 2021: a nationwide population-based cohort studyBerhe W Sahle, Dianna J Magliano, Andre M N Renzaho, et al.Clinical Journal of the American Society of Nephrology : CJASN|April 23, 2015
Rate of change in renal function and mortality in elderly treated hypertensive patientsEnayet K Chowdhury, Robyn G Langham, Zanfina Ademi, et al.Journal of Immune Based Therapies and Vaccines|April 13, 2007
A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapyGareth Ad Hardy, Nesrina Imami, Mark R Nelson, et al.Geriatrics (Basel, Switzerland)|July 25, 2023
Socio-Demographic, Lifestyle, and Clinical Characteristics of Early and Later Weight Status in Older Adults: Secondary Analysis of the ASPREE Trial and ALSOP Sub-StudyTagrid A Alharbi, Alice J Owen, Joanne Ryan, et al.American Heart Journal|September 21, 2015
Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)Sameer Bansilal, Zachary Bloomgarden, Jonathan L Halperin, et al.Pageof 73